Feng Y - Search Results

1

Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.

Chang CC, Zhou X, Taylor JJ, Huang WT, Ren X, Monzon F, Feng Y, Rao PH, Lu XY, Fabio F, Hilsenbeck S, Creighton CJ, Jaffe ES, Lau CC. Chang CC, et al. Among authors: feng y. J Hematol Oncol. 2009 Nov 12;2:47. doi: 10.1186/1756-8722-2-47. J Hematol Oncol. 2009. PMID: 19909553 Free PMC article.

2

Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.

Conway EJ, Wen J, Feng Y, Mo A, Huang WT, Keever-Taylor CA, Hari P, Vesole DH, Chang CC. Conway EJ, et al. Among authors: feng y. Arch Pathol Lab Med. 2009 Oct;133(10):1594-9. doi: 10.5858/133.10.1594. Arch Pathol Lab Med. 2009. PMID: 19792049 Free article.

3

Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.

Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: feng y. Leuk Res. 2010 Jan;34(1):85-92. doi: 10.1016/j.leukres.2009.05.024. Epub 2009 Jul 15. Leuk Res. 2010. PMID: 19608275

4

Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.

Zhang P, Zhao N, Zeng Z, Feng Y, Tung CH, Chang CC, Zu Y. Zhang P, et al. Among authors: feng y. Lab Invest. 2009 Dec;89(12):1423-32. doi: 10.1038/labinvest.2009.113. Epub 2009 Oct 12. Lab Invest. 2009. PMID: 19823169 Free PMC article.

5

Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells.

Feng Y, Wen J, Mike P, Choi DS, Eshoa C, Shi ZZ, Zu Y, Chang CC. Feng Y, et al. Stem Cells Dev. 2010 Sep;19(9):1289-96. doi: 10.1089/scd.2010.0010. Stem Cells Dev. 2010. PMID: 20121456

6

P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.

Wen J, Cheng HY, Feng Y, Rice L, Liu S, Mo A, Huang J, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: feng y. Br J Haematol. 2008 Jan;140(2):169-80. doi: 10.1111/j.1365-2141.2007.06895.x. Br J Haematol. 2008. PMID: 18173754 Free article.

7

Unique biomechanical interactions between myeloma cells and bone marrow stroma cells.

Feng Y, Ofek G, Choi DS, Wen J, Hu J, Zhao H, Zu Y, Athanasiou KA, Chang CC. Feng Y, et al. Prog Biophys Mol Biol. 2010 Sep;103(1):148-56. doi: 10.1016/j.pbiomolbio.2009.10.004. Epub 2009 Oct 17. Prog Biophys Mol Biol. 2010. PMID: 19840813 Review.

8

Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.

Wen J, Feng Y, Bjorklund CC, Wang M, Orlowski RZ, Shi ZZ, Liao B, O'Hare J, Zu Y, Schally AV, Chang CC. Wen J, et al. Among authors: feng y. Mol Cancer Ther. 2011 Jan;10(1):148-58. doi: 10.1158/1535-7163.MCT-10-0829. Epub 2010 Nov 9. Mol Cancer Ther. 2011. PMID: 21062912

9

p38 Mitogen-activated protein kinase and hematologic malignancies.

Feng Y, Wen J, Chang CC. Feng Y, et al. Arch Pathol Lab Med. 2009 Nov;133(11):1850-6. doi: 10.5858/133.11.1850. Arch Pathol Lab Med. 2009. PMID: 19886722 Free article. Review.

10

Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions.

Wen J, Tao W, Kuiatse I, Lin P, Feng Y, Jones RJ, Orlowski RZ, Zu Y. Wen J, et al. Among authors: feng y. Int J Cancer. 2015 Mar 1;136(5):991-1002. doi: 10.1002/ijc.29078. Epub 2014 Jul 23. Int J Cancer. 2015. PMID: 25042852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,781 results

Search Page

Filters